备注：LncRNA SNHG14促进宫颈癌的发展，预示预后不良。

IF 3.3 4区医学 Q1 Medicine

European review for medical and pharmacological sciences Pub Date : 2025-04-01 DOI:10.26355/eurrev_202504_37158

Y-Y Zhang, M Li, Y-D Xu, J Shang

{"title":"备注：LncRNA SNHG14促进宫颈癌的发展，预示预后不良。","authors":"Y-Y Zhang, M Li, Y-D Xu, J Shang","doi":"10.26355/eurrev_202504_37158","DOIUrl":null,"url":null,"abstract":"The article \"LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis\" by Y.-Y. Zhang, M. Li, Y.-D. Xu, J. Shang published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991 has been retracted in accordance with the Publisher and the Editor in Chief. The article has been retracted due to a critical error in the methodology. Specifically, the primers reported as targeting the SNHG14 gene were incorrect. A BLAST alignment of the cited primer sequences revealed that they do not significantly align with SNHG14, but instead match sequences from TALAM1/MALAT1. This error compromises the validity of the study's results. Therefore, the manuscript has been retracted. The authors were notified of the investigation and were asked to provide the raw data, but they have not responded. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17790.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 4","pages":"151"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.\",\"authors\":\"Y-Y Zhang, M Li, Y-D Xu, J Shang\",\"doi\":\"10.26355/eurrev_202504_37158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article \\\"LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis\\\" by Y.-Y. Zhang, M. Li, Y.-D. Xu, J. Shang published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991 has been retracted in accordance with the Publisher and the Editor in Chief. The article has been retracted due to a critical error in the methodology. Specifically, the primers reported as targeting the SNHG14 gene were incorrect. A BLAST alignment of the cited primer sequences revealed that they do not significantly align with SNHG14, but instead match sequences from TALAM1/MALAT1. This error compromises the validity of the study's results. Therefore, the manuscript has been retracted. The authors were notified of the investigation and were asked to provide the raw data, but they have not responded. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17790.\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"29 4\",\"pages\":\"151\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202504_37158\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202504_37158","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

《LncRNA SNHG14促进宫颈癌的发展并预测预后不良》一文由y - y撰写。张明，李彦德。Xu， J. Shang发表于《Eur Rev Med Pharmacol Sci 2019》；23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991已根据出版商和主编的要求撤回。由于方法上的一个严重错误，这篇文章已被撤回。具体来说，报道的针对SNHG14基因的引物是不正确的。对引物序列进行BLAST比对发现，它们与SNHG14不明显匹配，但与TALAM1/MALAT1序列匹配。这个错误损害了研究结果的有效性。因此，稿件已被撤回。调查通知了作者，并要求他们提供原始数据，但他们没有回应。这篇文章已被撤回。对于由此造成的任何不便，出版商深表歉意。https://www.europeanreview.org/article/17790。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.

The article "LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis" by Y.-Y. Zhang, M. Li, Y.-D. Xu, J. Shang published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991 has been retracted in accordance with the Publisher and the Editor in Chief. The article has been retracted due to a critical error in the methodology. Specifically, the primers reported as targeting the SNHG14 gene were incorrect. A BLAST alignment of the cited primer sequences revealed that they do not significantly align with SNHG14, but instead match sequences from TALAM1/MALAT1. This error compromises the validity of the study's results. Therefore, the manuscript has been retracted. The authors were notified of the investigation and were asked to provide the raw data, but they have not responded. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17790.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European review for medical and pharmacological sciences 医学-药学

CiteScore

5.30

自引率

6.10%

发文量

906

审稿时长

2-4 weeks

期刊介绍： European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)